Understanding how nuclear organization affects cell function
Interplay Between Nuclear Organization and Function
This study is looking at how a specific part of our DNA helps keep our cells healthy and stable, which could lead to better understanding and treatments for conditions related to DNA and cell function.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10994611 on NIH RePORTER |
What this research studies
This research investigates the role of Peri-Centromeric Heterochromatin (PCH) in maintaining genome stability and regulating essential cellular functions. By examining the biophysical properties and organization of PCH, the study aims to uncover how these factors influence DNA repair, chromosome pairing, and gene silencing. The approach involves advanced techniques to analyze the dynamics of chromatin in living cells, focusing on the formation of membrane-less condensates that play a critical role in nuclear architecture. Patients may benefit from insights gained into the fundamental mechanisms of cellular function and stability.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with genetic disorders or conditions related to genome instability.
Not a fit: Patients with conditions unrelated to chromatin organization or genome stability may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing genome stability and improving treatments for genetic disorders.
How similar studies have performed: Other research has shown promising results in understanding the role of chromatin organization in cellular functions, indicating that this approach has potential for significant advancements.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Karpen, Gary H — University of California Berkeley
- Study coordinator: Karpen, Gary H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.